Accuray Incorporated experienced a challenging second quarter of fiscal year 2026, with total net revenue decreasing by 12% to $102.2 million and a net loss of $13.8 million. The company initiated a significant transformational plan, including restructuring charges of $6.1 million, to reduce costs and align resources with strategic priorities, aiming for an annualized operating profit improvement of approximately $25 million.

Accuray experienced a challenging first quarter of fiscal 2026 with total net revenue decreasing by 7% to $93.9 million and a net loss of $21.7 million, or $0.18 per share. Product revenue saw a substantial 23% decline, while service revenue increased by 7%. The company initiated a restructuring plan and introduced the Accuray Stellar™ Solution, aiming for future growth amidst soft current results.

Accuray's fourth quarter of fiscal 2025 saw a 5% decrease in net revenue to $127.5 million, with net income falling to $1.1 million from $3.4 million in the prior year. Despite these declines, the company achieved a book-to-bill ratio of 1.2 and maintained strong service revenue growth. For the full fiscal year 2025, net revenue increased by 3% to $458.5 million, and the company significantly reduced its net loss.

Accuray delivered a strong fiscal third quarter with a 12% increase in total net revenue and a significant improvement in net loss and Adjusted EBITDA compared to the prior year period. Despite a decrease in gross product orders, the company maintained a book-to-bill ratio above 1 and ended the quarter with a substantial order backlog.

Accuray Incorporated reported a net income of $2.537 million for the three months ended December 31, 2024, a substantial improvement compared to a net loss of $9.621 million in the same period last year. This positive shift was primarily driven by a 19% increase in product revenue, reaching $61.189 million, and a 17% increase in gross profit. The company's total net revenue grew by 8% to $116.174 million, despite a slight decrease in service revenue. Operating expenses decreased by 7%, contributing to the improved profitability.

Accuray reported a slight decrease in total net revenue for Q1 2025 compared to the prior year, but saw strength in the China region and growth in its service business. The company raised its fiscal year 2025 revenue and adjusted EBITDA guidance.

Accuray reported a strong fourth quarter with a 13.5% increase in net revenue to $134.3 million and a GAAP net income of $3.4 million, compared to a net loss in the prior year. The company achieved record quarterly system shipments and secured new product approvals. They issued FY25 revenue guidance of $460 to $470 million and adjusted EBITDA guidance of $27.5 to $29.5 million.

Accuray Incorporated reported a decrease in net revenue for the third quarter of fiscal year 2024, alongside a GAAP net loss, but experienced a significant increase in gross orders. The company is focusing on long-term growth and profitability drivers through innovation, market penetration, and service business investments.

Accuray reported a decrease in revenue by 7% year-over-year to $107.2 million, but gross orders increased by 19% to $93.9 million. The company's GAAP net loss was $9.6 million, compared to a net loss of $1.9 million in the same period last year.

Accuray reported a strong first quarter for fiscal year 2024, with a 7.7% increase in net revenue to $103.9 million and a GAAP net loss of $3.0 million, compared to a net loss of $5.4 million in the same period last year. The company also achieved an adjusted EBITDA of $6.5 million and highlighted key new product introductions and regulatory milestones.

Accuray reported a 7.5% increase in Q4 revenue to $118.3 million, with a GAAP net loss of $2.6 million. The company's gross orders reached $88.4 million, resulting in a book-to-bill ratio of 1.4. They issued guidance for FY24.

Accuray reported a strong third quarter with a 22.8% increase in net revenue to $118.1 million and a GAAP net income of $0.6 million, driven by growing global demand for its radiotherapy solutions. The company shipped a record 30 systems and achieved its 1,000+ installed system milestone.

Accuray reported a slight decrease in revenue to $114.8 million, a 1.3% decrease year-over-year, impacted by supply chain constraints and foreign exchange headwinds. However, adjusted EBITDA increased by 24.1% to $8.5 million. The company reaffirmed its fiscal year 2023 guidance.

Accuray reported a decrease in revenue by 10% compared to the same period in the prior fiscal year, mainly driven by supply chain constraints and foreign exchange headwinds. The company is re-affirming guidance for fiscal year 2023.

Accuray reported a solid fourth quarter, beating consensus despite supply chain disruption and impacts from COVID-19 lockdowns in China, with historic revenue levels demonstrating strong customer adoption of their latest product innovation.

Accuray reported a decrease in revenue and a net loss for the third quarter of fiscal year 2022. Total net revenue was $96.2 million, a 6% decrease compared to the prior year. The company experienced a net loss of $1.0 million, compared to a net loss of $0.4 million in the prior year.

Accuray reported a record net revenue of $116.3 million for the second quarter of fiscal year 2022, representing a 19% increase compared to the prior year. GAAP net income was $0.2 million, and adjusted EBITDA was $6.8 million.

Accuray reported a strong start to fiscal year 2022, with record first quarter revenue of $107.4 million, driven by investments in product innovation and commercial execution. However, the company experienced a net loss of $1.0 million compared to a net income of $0.4 million in the prior year.

Accuray reported a strong Q4 with a 17% increase in revenue and a 19% increase in gross orders compared to the prior year. The company finished the fiscal year with a record ending backlog and managed expenses effectively.

Accuray reported a net revenue of $102.6 million for the third quarter of fiscal year 2021, which includes $24.9 million of system revenue in China. The company's GAAP operating income was $4.4 million, but they experienced a net loss of $0.4 million. Gross orders totaled $87.4 million, and the ending backlog increased by 7 percent from the previous year to $610.8 million.

Accuray Incorporated reported a net revenue of $97.5 million for the second quarter of fiscal year 2021, which includes $21.3 million of system revenue in China. The company's GAAP operating income was $8.2 million and GAAP net income was $4.8 million. Adjusted EBITDA grew to $13.5 million. They also received FDA clearance for ClearRT™ Helical kVCT Imaging for the Radixact® System.

Accuray reported a solid start to fiscal year 2021 with net revenue of $85.3 million and operating income of $5.5 million. Adjusted EBITDA grew to $9 million, and the ending backlog increased by 21 percent from the previous year.

Accuray reported a solid performance in Q4 2020, with gross orders of $94.3 million and net revenue of $95.0 million. The company generated $19.2 million in operating cash flow and ended the quarter with $108.6 million in cash and short-term restricted cash. Despite a net loss of $0.8 million, Adjusted EBITDA was $9.3 million. The company's ending backlog increased by 22 percent from the prior year.

Accuray reported a solid third fiscal quarter with a 27% year-over-year increase in gross orders, reaching $106 million. Net revenue was $99.5 million and net income was $2.6 million, or $0.03 per share. The company ended the quarter with $91.6 million in cash, cash equivalents, and short-term restricted cash.

Accuray reported solid financial and operational results for Q2 2020, with net revenue of $98.8 million and net income of $10.7 million. Gross orders totaled $98.6 million and backlog increased 12% year over year to $539.4 million. Adjusted EBITDA was $7.1 million.